Synaptic inhibition mediated by GABAB receptors in the neonatal rat spinal cord in vitro

Brain Research

Volumn 717, Issue 1-2, 1996, Pages 76-80

  Lacey, Gary ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

GABA; GABAB; In vitro; Prolonged inhibition; Rat; Spinal cord

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; BICUCULLINE; CGP 56999A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; SPINAL CORD; TISSUE SLICE;

ANIMALS; ANIMALS, NEWBORN; BACLOFEN; BICUCULLINE; GABA AGONISTS; GABA ANTAGONISTS; GANGLIA, SPINAL; NEURAL INHIBITION; RATS; RATS, WISTAR; RECEPTORS, GABA-B; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0029972096     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00534-3     Document Type: Article

References (19)

1. Bagust, J., Green, K.A. and Kerkut, G.A., Strychnine sensitive inhibition in the dorsal horn of the mammalian spinal cord, Brain. Res., 217 (1981) 425-429.
2. Bowery, N.G., GABA-B receptor pharmacology, Annu. Rev. Pharmacol. Toxicol., 33 (1993) 109-147.
3. Caddick, S.J., Stanford, I.M. and Chad, J.E., 2-hydroxy-saclofen causes a phaclofen-reversible reduction in population spike amplitude in the rat hippocampal slice, Eur. J. Pharmacol., 274 (1995) 41-46.
4. Cook, W.A. and Cangiano, A., Presynaptic and postsynaptic inhibition of motoneurones, J. Neurophysiol., 35 (1972) 389-403.
5. Curtis, D.R., Duggan, A.W., Felix, D. and Johnston, G.A.R., Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat, Brain Res., 32 (1971) 69-96.
6. Curtis, D.R., Gynther, B.D., Beattie, D.T., Kerr, D.I. and Prager, R.H., Baclofen antagonism by 2-hydroxy-saclofen in the cat spinal cord, Neurosci. Lett., 92 (1988) 97-101.
7. Curtis, D.R., Lodge, D., Bornstein, J.C. and Peet, M.J., Selective effects of (-)-baclofen on spinal synaptic transmission in the cat, Exp. Brain Res., 42 (1981) 158-170.
8. Curtis, D.R. and Lacey, G., GABA-B receptor mediated spinal inhibition, Neuroreport, 5 (1994) 540-542.
9. Dolphin, A.C. and Scott, R.H., Calcium channel currents and their inhibition by (-)-baclofen in rat sensory neurones: modulation by guanine nucleotides, J. Physlol., 386 (1987) 1-17.
10. Dutar, P. and Nicoll, R.A., Pre- and postsynaptic GABA-B receptors in the hippocampus have different pharmacological properties, Neuron, 1 (1988) 585-591.
11. Eccles, J.C., Schmidt, R.F. and Willis, W.D., The mode of operation of the synaptic mechanism producing presynaptic inhibition, J. Neurophysiol., 26 (1963) 523-538.
12. Evans, R.H., Evidence supporting the indirect depolarisation of primary afferent terminals in the frog by excitatory amino acids, J. Physiol., 298 (1980) 25-35.
13. Frank, K. and Fuortes, M.G.F., presynaptic and postsynaptic inhibition of monosynaptic reflexes., Fed. Proc., 16 (1957) 39-40.
14. Mott, D.D. and Lewis, D.V., The pharmacology and function of central GABA-B receptors, Int. Rev. Neurobiol., 36 (1994) 97-223.
15. Otsuka, M. and Konishi, S., Electrophysiology of mammalian spinal cord in vitro, Nature, 252 (1974) 733-734.
16. Quevedo, J., Eguibar, J.R., Jimenez, I. and Rudomin, P., Differential action of (-)-baclofen on the primary afferent depolarization produced by segmental and descending inputs, Exp. Brain Res., 91 (1992) 29-45.
17. Solis, J.M. and Nicoll, R.A., Pharmacological characterisation of GABA-B mediated responses in the CA1 region of the rat hippocampal slice, J. Neurosci., 12 (1992) 3466-3472.
18. Stuart, G.J. and Redman, S.J., The role of GABA-A and GABA-B receptors in presynaptic inhibition of Ia EPSPs in cat spinal motoneurones, J. Physiol., 447 (1992) 675-692.
19. Waldmeier, P.C., Wicki, P., Feldtrauer, J.-J., Mickel, S.J., Bittiger, H. and Baumann, P.A., GABA and glutamate release affected by GABA-B receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors, Br. J. Pharmacol., 113 (1994) 1515-1521.